Affimed N.V. (AFMDQ)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Biotechnology	13.91M	42.67M	41.55M	28.86M	21.43M
Biotechnology Growth	-67.39%	2.70%	43.99%	34.66%	-9.68%
Total	13.91M	42.67M	41.55M	28.86M	21.43M
Total Growth	-67.39%	2.70%	43.99%	34.66%	-9.68%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Germany	5.00K	152.00K	742.00K	194.00K	-
Germany Growth	-96.71%	-79.51%	282.47%	-	-
USA	8.27M	41.20M	39.62M	28.16M	19.75M
USA Growth	-79.93%	3.98%	40.69%	42.64%	-12.36%
Europe	-	-	-	2.00K	1.65M
Europe Growth	-	-	-	-99.88%	40.09%
Total	8.28M	41.35M	40.37M	28.36M	21.39M
Total Growth	-79.99%	2.45%	42.33%	32.58%	-9.88%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error